Future Frontiers in Heart Failure
Author:
Marín-García José
Reference123 articles.
1. Sugden PH, Clerk A (1998) “Stress-responsive” mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83:345–352
2. McKinsey TA, Olson EN (2005) Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. Clin Invest 115:538–546
3. Nanni L, Romualdi C, Maseri A, Lanfranchi G (2006) Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol 41:934–948
4. Mani K, Kitsis RN (2003) Myocyte apoptosis: programming ventricular remodeling. J Am Coll Cardiol 41:761–764
5. Park M, Shen YT, Gaussin V, Heyndrickx GR, Bartunek J, Resuello RG, Natividad FF, Kitsis RN, Vatner DE, Vatner SF (2009) Apoptosis predominates in non-myocytes in heart failure. Am J Physiol Heart Circ Physiol 297:H785–H791